Accuray (ARAY) Assets Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.43% |
| Dec 31, 2025 | 34.55% |
| Sep 30, 2025 | 61.21% |
| Jun 30, 2025 | 63.21% |
| Mar 31, 2025 | 41.79% |
| Dec 31, 2024 | -19.81% |
| Sep 30, 2024 | -19.68% |
| Jun 30, 2024 | -20.11% |
| Mar 31, 2024 | -22.31% |
| Dec 31, 2023 | -20.67% |
| Sep 30, 2023 | -21.78% |
| Jun 30, 2023 | -24.86% |
| Mar 31, 2023 | -23.10% |
| Dec 31, 2022 | -23.94% |
| Sep 30, 2022 | -25.21% |
| Jun 30, 2022 | -25.72% |
| Mar 31, 2022 | -25.84% |
| Dec 31, 2021 | -27.27% |
| Sep 30, 2021 | -27.98% |
| Jun 30, 2021 | -34.98% |
| Mar 31, 2021 | -37.22% |
| Dec 31, 2020 | -38.30% |
| Sep 30, 2020 | -38.10% |
| Jun 30, 2020 | -38.64% |
| Mar 31, 2020 | -41.09% |
| Dec 31, 2019 | 0.50% |
| Sep 30, 2019 | 0.18% |
| Jun 30, 2019 | -2.42% |
| Mar 31, 2019 | -3.73% |
| Dec 31, 2018 | -4.47% |
| Sep 30, 2018 | -4.84% |
| Jun 30, 2018 | -4.47% |
| Mar 31, 2018 | -4.87% |
| Dec 31, 2017 | -0.08% |
| Sep 30, 2017 | -2.10% |
| Jun 30, 2017 | -2.99% |
| Mar 31, 2017 | -3.29% |
| Dec 31, 2016 | -3.34% |
| Sep 30, 2016 | -3.30% |
| Jun 30, 2016 | 0.57% |